A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
- PMID: 7509044
- DOI: 10.1038/367645a0
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Abstract
Most human acute myeloid leukaemia (AML) cells have limited proliferative capacity, suggesting that the leukaemic clone may be maintained by a rare population of stem cells. This putative leukaemic stem cell has not been characterized because the available in vitro assays can only detect progenitors with limited proliferative and replating potential. We have now identified an AML-initiating cell by transplantation into severe combined immune-deficient (SCID) mice. These cells homed to the bone marrow and proliferated extensively in response to in vivo cytokine treatment, resulting in a pattern of dissemination and leukaemic cell morphology similar to that seen in the original patients. Limiting dilution analysis showed that the frequency of these leukaemia-initiating cells in the peripheral blood of AML patients was one engraftment unit in 250,000 cells. We fractionated AML cells on the basis of cell-surface-marker expression and found that the leukaemia-initiating cells that could engraft SCID mice to produce large numbers of colony-forming progenitors were CD34+ CD38-; however, the CD34+ CD38+ and CD34- fractions contained no cells with these properties. This in vivo model replicates many aspects of human AML and defines a new leukaemia-initiating cell which is less mature than colony-forming cells.
Similar articles
-
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.Blood. 2001 Jun 15;97(12):3882-9. doi: 10.1182/blood.v97.12.3882. Blood. 2001. PMID: 11389030
-
Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.Blood. 1996 Oct 1;88(7):2655-64. Blood. 1996. PMID: 8839860
-
Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.Blood. 1999 Jul 15;94(2):529-38. Blood. 1999. PMID: 10397720
-
Immunophenotypic features of early haematopoietic and leukaemia stem cells.Int J Lab Hematol. 2024 Oct;46(5):795-808. doi: 10.1111/ijlh.14348. Epub 2024 Jul 24. Int J Lab Hematol. 2024. PMID: 39045906 Review.
-
Leukemia stem cells: Old concepts and new perspectives.Mol Aspects Med. 2014 Oct;39:102-9. doi: 10.1016/j.mam.2013.06.003. Epub 2013 Jun 29. Mol Aspects Med. 2014. PMID: 23820118 Free PMC article. Review.
Cited by
-
Immune evasion by cancer stem cells.Regen Ther. 2021 Mar 11;17:20-33. doi: 10.1016/j.reth.2021.02.006. eCollection 2021 Jun. Regen Ther. 2021. PMID: 33778133 Free PMC article. Review.
-
Animal models of leukemia: any closer to the real thing?Cancer Metastasis Rev. 2013 Jun;32(1-2):63-76. doi: 10.1007/s10555-012-9405-5. Cancer Metastasis Rev. 2013. PMID: 23081702 Free PMC article. Review.
-
PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.Cell Cycle. 2021 May;20(10):1010-1020. doi: 10.1080/15384101.2021.1919826. Epub 2021 May 10. Cell Cycle. 2021. PMID: 33970778 Free PMC article.
-
TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia.Oncotarget. 2015 Aug 28;6(25):20977-92. doi: 10.18632/oncotarget.4007. Oncotarget. 2015. PMID: 26023795 Free PMC article.
-
Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.Clin Transl Oncol. 2012 Aug;14(8):575-85. doi: 10.1007/s12094-012-0844-9. Epub 2012 Jul 21. Clin Transl Oncol. 2012. PMID: 22855139
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials